Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
5.37
-0.06 (-1.11%)
At close: Dec 20, 2024, 4:00 PM
5.63
+0.26 (4.84%)
After-hours: Dec 20, 2024, 4:51 PM EST
MRVI Analyst Ratings
Total Analysts
10
Consensus Rating
Buy
Price Target
$10.28
Upside
+91.43%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold → Strong Sell Downgrades $7 → $4.25 | Hold → Strong Sell | Downgrades | $7 → $4.25 | -20.86% | Dec 5, 2024 |
| Wolfe Research | Wolfe Research | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Nov 14, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $17 → $13 | Buy | Maintains | $17 → $13 | +142.09% | Nov 8, 2024 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 8, 2024 |
| Baird | Baird | Buy Maintains $10 → $9 | Buy | Maintains | $10 → $9 | +67.60% | Nov 8, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +30.35% | Oct 8, 2024 |
| Wells Fargo | Wells Fargo | Buy Initiates $10 | Buy | Initiates | $10 | +86.22% | Aug 27, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $15 | Buy | Reiterates | $15 | +179.33% | Aug 16, 2024 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $11 → $10 | Buy → Hold | Downgrades | $11 → $10 | +86.22% | Aug 13, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $7 → $8 | Hold | Maintains | $7 → $8 | +48.98% | Aug 8, 2024 |
| UBS | UBS | Hold Maintains $8.5 → $11 | Hold | Maintains | $8.5 → $11 | +104.84% | Aug 8, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +30.35% | Jul 9, 2024 |
| Baird | Baird | Buy Maintains $8 → $10 | Buy | Maintains | $8 → $10 | +86.22% | May 9, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +179.33% | Apr 10, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $12 → $14 | Buy | Maintains | $12 → $14 | +160.71% | Feb 23, 2024 |
| Stifel | Stifel | Strong Buy Maintains $11 → $10 | Strong Buy | Maintains | $11 → $10 | +86.22% | Feb 23, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.